Cargando…

Feasibility of implementing the ‘Screening for Distress and Referral Need’ process in 23 Dutch hospitals

PURPOSE: In the Netherlands, the three-step process ‘Screening for Distress and Referral Need’ (SDRN) was developed for helping identifying, and referring cancer patients suffering from clinically relevant distress or needing a referral. This process includes (1) instrument completion, (2) patient-c...

Descripción completa

Detalles Bibliográficos
Autores principales: van Nuenen, F. M., Donofrio, S. M., Tuinman, M. A., van de Wiel, H. B. M., Hoekstra-Weebers, J. E. H. M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5127859/
https://www.ncbi.nlm.nih.gov/pubmed/27565789
http://dx.doi.org/10.1007/s00520-016-3387-8
Descripción
Sumario:PURPOSE: In the Netherlands, the three-step process ‘Screening for Distress and Referral Need’ (SDRN) was developed for helping identifying, and referring cancer patients suffering from clinically relevant distress or needing a referral. This process includes (1) instrument completion, (2) patient-care provider discussion of the responses, and (3) referral based on 1 and 2. The Netherlands Comprehensive Cancer Organisation, location Groningen (IKNL-G), initiated the implementation of SDRN and developed an implementation roadmap, including procedure and materials. This exploratory study examines the feasibility of SDRN implementation in hospitals, seen from healthcare providers’ perspective, responsible for implementation, and those executing SDRN. METHODS: Healthcare providers, from 22 hospitals and from 5 oncology departments of the University Medical Center Groningen (=25 % of Dutch hospitals), evaluated their experiences by responding to a 26-item internet survey. RESULTS: Twenty-five participants (response = 93 %) completed the survey. SDRN was implemented in 21 hospitals (implementation = 91 %), in two thirds of these hospitals in more than one patient group. Adoption of IKNL-G’s roadmap elements varied between 84 and 100 %. Participants’ average satisfaction score with SDRN was 6.5 (possible range = 0–10, range found = 5–8). Significant positive relationships were found between this satisfaction and participants’ satisfaction with frequency of SDRN (p = 0.02), and keeping logistical agreements (p = 0.04). Participants were dissatisfied with SDRN’s limited current availability to only select patient groups and only certain disease phases. CONCLUSIONS: The implementation of SDRN in daily practice, supported by a pre-developed implementation roadmap, is highly feasible. Continuous attention to SDRN execution, broadening implementation to all forms of cancer, and during the total disease trajectory seems vital to improve healthcare providers’ satisfaction.